European Union regulators on Thursday fined Israeli drug-maker Teva for colluding to delay a cheaper generic version of modafinil, a blockbuster sleep disorder drug, AFP reports.
The European Commission said Teva was in breach of EU antitrust rules after it effectively agreed with drug-maker Cephalon, a company it now owns, to keep the cheaper drug off of the market.
Read more